New research reveals that intermittent fasting can significantly enhance the effectiveness of oestrogen-blocking breast ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with ...

Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to hormone therapy? In a recently published study, she shared a new theory as to ...

Enclomiphene is a non-steroidal selective estrogen receptor modulator (SERM) sometimes used to treat male secondary hypogonadism, or low testosterone caused by problems with the hypothalamus or ...

Puberty blockers will be tested on children with gender dysphoria, researchers have announced, after a major independent inquiry led to the overhaul of NHS gender services. Researchers from King's ...

Details of a new UK clinical trial to assess the risks and benefits of puberty-blocking drugs in children who question their gender have been announced. It follows the banning of the drugs for gender ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? The FDA has announced that it is removing the black box warning from estrogen ...